Long-term cancer survivors treated with multiple courses of repeat radiation therapy. 2021

Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. sebastian.christ@usz.ch.

BACKGROUND Through recent advances in cancer care, the number of long-term survivors has continuously increased. As a result, repetitive use of local radiotherapy for curative or palliative indications might have increased as well. This analysis aims to describe patterns of care and outcome of patients treated with multiple courses of repeat radiotherapy. METHODS All patients treated with radiotherapy between 2011 and 2019 at our department of Radiation Oncology were included into this analysis. A course of radiotherapy was defined as all treatment sessions to one anatomical site under one medical indication. Demographics, cancer and treatment characteristics and overall survival of patients having undergone multiple radiotherapy courses (minimum n = 5) were evaluated. RESULTS The proportion of cancer patients treated with a minimum five courses of radiotherapy increased continuously from 0.9% in 2011 to 6.5% in 2019. In the 112 patients treated with a minimum of five radiotherapy courses, the primary tumor was lung in 41.9% (n = 47), malignant melanoma in 8.9% (n = 10) and breast in 8.0% (n = 9) of cases. A median interval of 3 years (maximum 8 years) elapsed between the first and the last radiotherapy course. The maximum number of courses in a single patient were n = 10. Treatment intent was curative or palliative in 46.4% and 53.6% for the first radiotherapy, respectively. The proportion of curative intent decreased to 11.6% at the 5th, and the last radiotherapy course was following a palliative intent in all patients. Five-year overall survival measured from the 1st radiotherapy course was 32.7%. Median overall survival was 3.3, 2.4, 1.3, and 0.6 years when measured from the 1st, the 1st palliative, the 5th and last course of radiotherapy, respectively. CONCLUSIONS A continuously increasing number of patients is treated with multiple courses of radiotherapy throughout their long-term cancer survivorship.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069475 Re-Irradiation Treatment in which a repeat course of RADIOTHERAPY is administered. Re Irradiation,Reirradiation
D000073116 Cancer Survivors Persons who have experienced prolonged survival with or following malignant neoplastic disease. Cancer Survivorship,Survivors of Childhood Cancer,Long-Term Cancer Survivors,Cancer Survivor,Cancer Survivor, Childhood,Cancer Survivor, Long-Term,Cancer Survivors, Childhood,Cancer Survivors, Long-Term,Childhood Cancer Survivor,Childhood Cancer Survivors,Long Term Cancer Survivors,Long-Term Cancer Survivor,Survivor, Long-Term Cancer,Survivors, Cancer,Survivors, Long-Term Cancer,Survivorship, Cancer
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
September 2013, JAMA otolaryngology-- head & neck surgery,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
December 1988, Gan no rinsho. Japan journal of cancer clinics,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
December 1984, Gan no rinsho. Japan journal of cancer clinics,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
May 2013, British journal of cancer,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
February 2014, Psycho-oncology,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
June 1981, Cancer,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
January 1994, Seminars in roentgenology,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
January 1995, Journal of neuro-oncology,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
January 2019, The Journal of veterinary medical science,
Sebastian M Christ, and Maiwand Ahmadsei, and Lotte Wilke, and Anja Kühnis, and Matea Pavic, and Stephanie Tanadini-Lang, and Matthias Guckenberger
November 2003, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!